Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis

Figure 1

Changes in HOMA and QUICKI following six months of anti-TNFα treatment. Anti-TNFα treatment significantly improves HOMA and QUICKI only in the N+IR group. * Significant difference compared to baseline. HOMA, homeostasis model assessment of insulin resistance; QUICKI, quantitative insulin sensitivity check index; N+IR, normal weight with insulin resistance; N-IR, normal weight without insulin resistance; O+IR, obese with insulin resistance; O-IR, obese without insulin resistance.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us